According to Medtronic, its Talent thoracic stent graft system makes thoracic endovascular aortic repair accessible to an additional 25% of patients, because of its unique features. It is available in the widest range of diameters – from 22mm to 46mm, the company said. This size matrix offers physicians multiple options to customize devices for their patients’ needs and to treat a wider range of anatomies than with the other available endografts, claims the company.
Ronald Fairman, professor of surgery at the University of Pennsylvania Hospital, said: “FDA approval of the Talent thoracic stent graft is an important development in physicians’ abilities to treat this life-threatening condition. In my own experience, this device offers a superior alternative to open surgery and will allow physicians to perform minimally invasive thoracic aortic aneurysm repair for a broader population of patients.”